Design Therapeutics, Inc.

DSGN · Nasdaq · SIC 2834: Pharmaceutical Preparations
62
SEC Filings

Business Summary

7 Item 1A. Risk Factors 54 Item 1B. Unresolved Staff Comments 114 Item 1C. Cybersecurity 114 Item 2. Properties 115 Item 3. Legal Proceedings 116 Item 4. Mine Safety Disclosures 116 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 117 Item 6. [Reserved] 117 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 118 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 12...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionDSGNdiscussed_in_filing Cybersecurity
topic_mentionDSGNdiscussed_in_filing Cybersecurity
topic_mentionDSGNdiscussed_in_filing Cybersecurity
topic_mentionDSGNdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-098491EDGAR96K words
2025-03-102024-12-310000950170-25-035910EDGAR—
2024-03-192023-12-310000950170-24-033492EDGAR—
2023-03-142022-12-310000950170-23-007869EDGAR—
2022-03-102021-12-310000950170-22-003369EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266970EDGAR65K words
2025-08-072025-06-300000950170-25-105062EDGAR—
2025-05-072025-03-310000950170-25-065643EDGAR—
2024-11-072024-09-300000950170-24-123349EDGAR—
2024-08-052024-06-300000950170-24-090337EDGAR—
2024-05-082024-03-310000950170-24-055788EDGAR—
2023-11-132023-09-300000950170-23-062958EDGAR—
2023-08-142023-06-300000950170-23-042411EDGAR—
2023-05-092023-03-310000950170-23-019714EDGAR—
2022-11-032022-09-300000950170-22-021885EDGAR—
2022-08-082022-06-300000950170-22-015533EDGAR—
2022-05-092022-03-310000950170-22-008500EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001193125-26-137861EDGAR1K words
2026-03-090001193125-26-098474EDGAR—
2026-01-300001193125-26-031772EDGAR—
2025-11-050001193125-25-266933EDGAR—
2025-09-100001807120-25-000004EDGAR—
2025-08-070000950170-25-105008EDGAR—
2025-06-120000950170-25-085380EDGAR—
2025-05-070000950170-25-065613EDGAR—
2025-03-100000950170-25-035909EDGAR—
2025-01-130000950170-25-004612EDGAR—

62 total filings indexed. 35 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001807120
TickerDSGN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b446db8531776c55f8f16342df8b599f0462a15a052f9b403ec892a130a6c9f9
parent: 0b33b5937f716c6d82e491d8143f834f9d1a03ae6af7caf4ab26f092d9afe961
content hash: e6d7b5bd807ddaa28d8a008e54e4a39c601fc15f0f6611a5597b82a77f32bc9e
signed: 2026-04-13T04:44:43.338Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf